Go Pro

Chardan Capital's Rating of QumulusAI on 8/26/2026

On August 26, 2026, Chardan Capital updated its outlook on QumulusAI (NASDAQ:QMLS) with the action "Reiterated Rating", keeping a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Chardan Capital

DateCompanyAction
9/29/2026
CAMP4 Therapeutics Corporation stock logo
CAMP
CAMP4 Therapeutics
Lower Price Target
9/25/2026
Kodiak AI, Inc. stock logo
KDK
Kodiak AI
Reiterated Rating
9/25/2026
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
Reiterated Rating
9/21/2026
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
Initiated Coverage
9/18/2026
Agenus Inc. stock logo
AGEN
Agenus
Initiated Coverage
9/16/2026
Corvex, Inc. stock logo
MOVE
Corvex
Set Price Target
More Ratings From Chardan Capital